Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Wrist-Worn tracker improve Parkinson's care?

NCT ID NCT03741920

Knowledge-focused Sponsor: Global Kinetics Corporation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a wrist-worn movement recorder, called the Personal KinetiGraph (PKG), helps doctors make better treatment decisions for people with Parkinson's disease. About 231 participants will be split into two groups: one where the doctor sees the PKG data during the visit, and one where they do not. The goal is to see if having this movement data leads to more medication changes or adjustments.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Personal KinetiGraph™ (PKG™) Movement Recording System (a wrist-worn device)
What this could lead to
If successful, this could show that using movement data from a wearable device helps doctors adjust Parkinson's medications more effectively.
What could go wrong
This is an observational study, not a treatment trial. The device only provides information; it does not directly improve symptoms. Results may not change patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

231 people

The number who actually took part.

Started

May 2017

Expected to finish

Oct 2025

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

46 to 83 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Able and willing to sign a written informed consent for study participation * Age 46 - 83 years at the time of consent (per PKG Indications for Use, see Technical Instructions Manual) * Responsive to dopaminergic medications Exclusion Criteria: * Contraindication to increasing dopaminergic therapy, such as current or treated freezing gait, symptomatic postural hypotension, or bothersome hallucinations * Wheelchair bound or bedridden * Utilizing or planning advanced PD therapies (DBS, infusion, etc.) * History of delirium in the past year * In the investigator's or sponsor's opinion, subject has any unstable or clinically significant condition that would impair the participant's ability to comply with study requirements or interfere with interpretation of the study endpoints (e.g., subject able to complete PKG wear instructions per Patient Instruction Manual, or ability to comply with required study procedures and visit schedule)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Parkinson disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Parkinson disease

Contacts and locations

Locations

  • Johns Hopkins Medical Institute

    Baltimore, Maryland, 21287, United States

  • Michigan State University

    East Lansing, Michigan, 49824, United States

  • New York University

    New York, New York, 10017, United States

  • Northwell Health

    Great Neck, New York, 11021, United States

  • Parkinson's Disease and Movement Disorders Center

    Boca Raton, Florida, 33486, United States

  • Sutter Health

    Sacramento, California, 95816, United States

  • University of California

    San Diego, California, 92037, United States

  • University of Florida

    Gainesville, Florida, 32604, United States

  • University of Kansas Medical Center

    Kansas City, Kansas, 66103, United States

  • University of Miami

    Miami, Florida, 33136, United States

  • University of South Florida

    Tampa, Florida, 33613, United States

  • University of Texas

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.